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TUMOURS are no longer regarded as wholly autonomous growths and there is
much recent evidence to suggest that human tumour growth is partly controlled
by immunological processes. It is therefore important to investigate the immuno-
logical reactivity ofpatients with cancer. Patients with established cancer have a
depressed immune system whether measured by humoral antibody formation
(Lytton, Hughes and Fulthorpe, 1964), delayed hypersensitivity reactions (Hughes
and Mackay, 1965), or homograft rejection rates (Southam and Pillemer, 1957),
but little is known ofthe immunological activity in the patient before the develop-
ment of the tumour. In an attempt to investigate this indirectly, the incidence
of allergic conditions in cancer patients and in control subjects has been studied.
Previous reports yielded conflicting results (Logan and Saker, 1955; Fisherman,
1960).
METHODS AND RESULTS
One hundred and fifty patients with malignant disease were studied. Those
with a reticulosis or leukaemia were excluded. One hundred and fifty patients
attending the Casualty Department or in the same hospital with a non-malignant
condition formed the control group. Each patient with malignant disease was
matched with an individual control patient for age and sex, and both groups came
from the same geographical area. All the patients were interviewed in the same
way, and each patient was asked directly if he suffered from asthma, hay fever,
nettle rash or eczema. The incidence of the various allergies is given in Table I.
TABLE I.-Incidence ofAllergies in Cancer and Control Groups
Allergy Cancer patients Control patients
Asthma . . . . 1 . 8
Hay Fever . . . . 4 . 18
Nettle Rash . . 3 . 8
Eczema . . . . 6 . 5
Total Patients with Allergies . 14 . 31
Some ofthe control patients exhibited multiple allergies. The difference between
these two groups is significant (P < 0.01).
The results were analysed according to the site of the primary tumour but no
difference was found between the incidence ofallergy and the various sites studied,
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a greatly reduced incidence of allergy compared with the control patients, but
there was no difference between the results in the male cancer and male control
group. These results are shown in Table II.
TABLE II. Incidence of Allergy and Sex of Patient
Sex Patiernts Allergic cancer patients Allergic control patients
Male 39 6 4
Female 111 8 27
These results show a significant reduction in the incidence of allergic conditions in
the female cancer group. P < 0 01.
Allergy and histology of the tumour
The histological sections of breast tumours from patients with an allergic
history were examined for the presence of lymphocytic infiltration. Black and
Speer (1959) and Daoud (1964) have shown that the presence of lymphocytic
infiltration of breast tumours is associated with a good prognosis and this may
represent an immune response to the tumour. None ofthe six tumours examined
showed marked lymphocytic infiltration.
DISCUSSION
These results show that the incidence of allergic disorders in a group of cancer
patients is significantly lower than in a control group, and that this difference is
confined to female patients. Logan and Saker (1955) reported different findings
from New Zealand. They found a history ofallergy (hay fever, asthma or eczema)
in 36 per cent of control patients, and 13 per cent of control patients. However,
their two groups were not matched for age and the sex incidence of the cases is
not given. Geographical factors may also influence the results. Fisherman (1960)
in a large series from America found an incidence of atopy of 3-2 per cent in a
group of cancer patients and of 12-9 per cent in a group of controls. He assumed
atopy to exist if either seasonal rhinitis, bronchial asthma or eczema was present.
The overall results in this series agrees with Fisherman's findings except that
Fisherman found no sex difference in the results. When the incidence of allergy
was studied in patients with Hodgkins disease both Divorin, Diamond and Craver
(1955) and Shier (1954) found it normal.
Burnet (1964) has proposed that carcinogenesis may occur more easily in
patients with a depressed immune system, and it is important to know if a group
of patients with a low incidence of allergy lack some protective immunological
capacity.
Two clinical findings can be taken as indirect evidenceforthepossible protective
effect of an allergic history against tumour development. Firstly, the symptoms
of many allergic disorders decrease with age, and at the same time the incidence of
cancer rises with age. Secondly, the low incidence of allergy in the female cancer
group compared with the very high incidence in the female control group does
suggest that the female allergic patients possess some protective capacity against
carcinogenesis.
Daoud (1964) showed that the presence of marked lymphocytic infiltration in436 W. D. MACKAY
breast tumours is associated with a good prognosis and may represent an immune
response by the patient against cancer specific antigens in the tumour. The lack
of correlation between the allergic disorders and lymphocytic infiltration of the
tumour is perhaps not surprising because allergic disorders are characterised by an
immediate type of skin sensitivity and not a delayed type cellular reaction.
Auto-immune disease, for example, rheumatoid arthritis, represents another
form of altered immunological activity. Duthie et al. (1964) have shown that
cancer occurs at the expected rate in a large series of patients with rheumatoid
arthritis followed up for a long period and cases of cancer occurring in association
with Hashimoto's disease have been reported (Blackburn and O'Gorman, 1961).
This type of altered host response does not appear to be associated with any
reduction in the incideince of tumour development.
What is the mechanism of this apparent protection possessed by allergic
patients? The low incidence of allergic complaints in cancer patients does not
mean that other parameters of immunological activity are depressed before the
tumouroccurs. Allergicpatients possess anormal antibodyproducing mechanism,
both humoral and cellular. Hughes and Mackay (1965) have shown that the
depression of the delayed hypersensitivity reactions such as the Mantoux test,
follows the development of the tumour and removal of the tumour may restore
positive skin reactions suggesting that the tumour has developed in its early stages
against a normal immune mechanism as measured by delayed hypersensitivity
reactions and humoral antibody production. Allergic patients represent the end
of a spectrum of immunological activity characterised by the ability to form
reagin-type antibodies. Serafini, Torrigani and Masala (1965) have shown that
allergic patients also have an increase in titre of certain organ specific auto-
antibodies and suggest that there may exist a state of " immunological hyper-
sensitivity" in allergic patients with reagins which facilitates the formation of
antibodies against weak antigens, such as pollen, thyroid and gastric antigens.
Evidence is accumulating that human cancer tissue contains antigens absent from
normal tissue (Tee, Wang and Watkins, 1964), and that there are indications that
cancer patients may respond to cancer tissue by an immunological reaction
(Hughes and Lytton, 1964). It is possible that a cancer specific antigen may be of
the same molecular pattern as organ specific antigens and the allergic patients
may give an immune response to cancer tissue.
The reagin-type antibodies are IgA globulins, and possess a great affinity to
tissue cells (Humphrey and White, 1964). This ability to adhere to cells may be
an effective method ofensuring the reaction ofantigen with antibody which results
in the early elimination of clones of cancer cells.
It is of great interest that reagin-type antibodies to tumour tissue have been
found in eight patients tested by Grace and Kondo (1958). All these patients
had tumours with evidence of surrounding inflammation indicating some form
of host response. Grace and Dao (1959) and Curtis, Heckaman and Wheeler
(1961) have reported positive immediate skin reactions by testing patients with
extracts oftheir own tumour and also passive transfer ofsensitivity with serum in
cases of breast and bronchial carcinoma associated with dermatomyosites. The
muscle changes in this condition may represent changes produced by antibody on
tissues with a shared antigen with the tumour. These changes show that reagin-
type antibodies may be produced by cancer patients and it may be that the ability
to do so is beneficial to the patient.ALLERGIC DISORDERS AND CANCER 437
SUMMARY
The incidence of allergic disorders in a group of cancer patients is significantly
less than the incidence in a group of control patients.
This finding is confined to female patients.
Possible implications of these results are discussed.
This work was carried out during the tenure of a full-time grant from the
British Empire Cancer Campaign for Research. I wish to thank Professor J. G.
Murray and Mr. Harold C. Edwards, Department of Surgery, King's College Hos-
pital, for their advice, and the surgeons ofthe hospital for permission tointerview
their patients.
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